Literature DB >> 21526769

Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin.

Nicholas A Treuheit1, Muneera A Beach, Elizabeth A Komives.   

Abstract

Several lines of experimental evidence including amide exchange and NMR suggest that ligands binding to thrombin cause reduced backbone dynamics. Binding of the covalent inhibitor dPhe-Pro-Arg chloromethyl ketone to the active site serine, as well as noncovalent binding of a fragment of the regulatory protein, thrombomodulin, to exosite 1 on the back side of the thrombin molecule both cause reduced dynamics. However, the reduced dynamics do not appear to be accompanied by significant conformational changes. In addition, binding of ligands to the active site does not change the affinity of thrombomodulin fragments binding to exosite 1; however, the thermodynamic coupling between exosite 1 and the active site has not been fully explored. We present isothermal titration calorimetry experiments that probe changes in enthalpy and entropy upon formation of binary ligand complexes. The approach relies on stringent thrombin preparation methods and on the use of dansyl-l-arginine-(3-methyl-1,5-pantanediyl)amide and a DNA aptamer as ligands with ideal thermodynamic signatures for binding to the active site and to exosite 1. Using this approach, the binding thermodynamic signatures of each ligand alone as well as the binding signatures of each ligand when the other binding site was occupied were measured. Different exosite 1 ligands with widely varied thermodynamic signatures cause a similar reduction in ΔH and a concomitantly lower entropy cost upon DAPA binding at the active site. The results suggest a general phenomenon of enthalpy-entropy compensation consistent with reduction of dynamics/increased folding of thrombin upon ligand binding to either the active site or exosite 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526769      PMCID: PMC3107735          DOI: 10.1021/bi2004069

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Electrostatic dependence of the thrombin-thrombomodulin interaction.

Authors:  A Baerga-Ortiz; A R Rezaie; E A Komives
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

2.  Molecular mapping of thrombin-receptor interactions.

Authors:  Y M Ayala; A M Cantwell; T Rose; L A Bush; D Arosio; E Di Cera
Journal:  Proteins       Date:  2001-11-01

Review 3.  Allostery: absence of a change in shape does not imply that allostery is not at play.

Authors:  Chung-Jung Tsai; Antonio del Sol; Ruth Nussinov
Journal:  J Mol Biol       Date:  2008-02-29       Impact factor: 5.469

4.  Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  M E Nesheim; F G Prendergast; K G Mann
Journal:  Biochemistry       Date:  1979-03-20       Impact factor: 3.162

5.  Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation.

Authors:  D J Stearns; S Kurosawa; C T Esmon
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

6.  Solvent accessibility of the thrombin-thrombomodulin interface.

Authors:  J G Mandell; A Baerga-Ortiz; S Akashi; K Takio; E A Komives
Journal:  J Mol Biol       Date:  2001-02-23       Impact factor: 5.469

7.  Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.

Authors:  P Fuentes-Prior; Y Iwanaga; R Huber; R Pagila; G Rumennik; M Seto; J Morser; D R Light; W Bode
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

8.  Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.

Authors:  Carrie Hughes Croy; Julia R Koeppe; Simon Bergqvist; Elizabeth A Komives
Journal:  Biochemistry       Date:  2004-05-11       Impact factor: 3.162

9.  A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site.

Authors:  S Kurosawa; D J Stearns; K W Jackson; C T Esmon
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

10.  Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles.

Authors:  Abel Baerga-Ortiz; Simon Bergqvist; Jeffrey G Mandell; Elizabeth A Komives
Journal:  Protein Sci       Date:  2004-01       Impact factor: 6.725

View more
  10 in total

1.  The dynamic structure of thrombin in solution.

Authors:  Brian Fuglestad; Paul M Gasper; Marco Tonelli; J Andrew McCammon; Phineus R L Markwick; Elizabeth A Komives
Journal:  Biophys J       Date:  2012-07-03       Impact factor: 4.033

2.  Through-bond effects in the ternary complexes of thrombin sandwiched by two DNA aptamers.

Authors:  Andrea Pica; Irene Russo Krauss; Valeria Parente; Hisae Tateishi-Karimata; Satoru Nagatoishi; Kouhei Tsumoto; Naoki Sugimoto; Filomena Sica
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

3.  Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.

Authors:  Lindsey D Handley; Nicholas A Treuheit; Varun J Venkatesh; Elizabeth A Komives
Journal:  Biochemistry       Date:  2015-10-26       Impact factor: 3.162

4.  How Thrombomodulin Enables W215A/E217A Thrombin to Cleave Protein C but Not Fibrinogen.

Authors:  Riley B Peacock; Taylor McGrann; Sofia Zaragoza; Elizabeth A Komives
Journal:  Biochemistry       Date:  2022-01-03       Impact factor: 3.321

5.  Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities.

Authors:  Paul M Gasper; Brian Fuglestad; Elizabeth A Komives; Phineus R L Markwick; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-28       Impact factor: 11.205

6.  Different DOACs Control Inflammation in Cardiac Ischemia-Reperfusion Differently.

Authors:  Ihsan Gadi; Sameen Fatima; Berend Isermann; Khurrum Shahzad; Ahmed Elwakiel; Sumra Nazir; Moh'd Mohanad Al-Dabet; Rajiv Rana; Fabian Bock; Jayakumar Manoharan; Dheerendra Gupta; Ronald Biemann; Bernhard Nieswandt; Ruediger Braun-Dullaeus; Christian Besler; Markus Scholz; Robert Geffers; John H Griffin; Charles T Esmon; Shrey Kohli
Journal:  Circ Res       Date:  2020-12-23       Impact factor: 17.367

7.  Correlated motions and residual frustration in thrombin.

Authors:  Brian Fuglestad; Paul M Gasper; J Andrew McCammon; Phineus R L Markwick; Elizabeth A Komives
Journal:  J Phys Chem B       Date:  2013-05-28       Impact factor: 2.991

8.  Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.

Authors:  Calvin H Yeh; Alan R Stafford; Beverly A Leslie; James C Fredenburgh; Jeffrey I Weitz
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

9.  NMR reveals a dynamic allosteric pathway in thrombin.

Authors:  Lindsey D Handley; Brian Fuglestad; Kyle Stearns; Marco Tonelli; R Bryn Fenwick; Phineus R L Markwick; Elizabeth A Komives
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

10.  Serine protease dynamics revealed by NMR analysis of the thrombin-thrombomodulin complex.

Authors:  Riley B Peacock; Taylor McGrann; Marco Tonelli; Elizabeth A Komives
Journal:  Sci Rep       Date:  2021-04-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.